| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 649,7 k € | -3.0% | 669,9 k € | +17.5% | 570,1 k € | -9.1% | 626,9 k € | +32.6% | 472,8 k € | -10.2% | 526,7 k € | +19.5% | 440,6 k € | +28.4% | 343,1 k € | -21.6% | 437,4 k € | +5.9% | 413,0 k € | +2.3% | 403,6 k € | -10.0% | 448,5 k € | +16.3% | 385,7 k € | -43.6% | 683,7 k € | +58.2% | 432,1 k € | +2.2% | 422,6 k € | +5.4% | 400,9 k € | +16.6% | 343,9 k € | -10.2% | 382,9 k € | |
| EBITDA | 616,1 k € | -3.3% | 636,8 k € | +19.9% | 530,9 k € | -13.8% | 615,8 k € | +33.1% | 462,6 k € | -10.6% | 517,6 k € | +20.5% | 429,7 k € | +28.8% | 333,5 k € | -22.0% | 427,3 k € | +6.0% | 403,1 k € | +3.0% | 391,4 k € | -10.6% | 438,0 k € | +16.9% | 374,6 k € | -44.5% | 674,7 k € | +61.1% | 418,8 k € | +0.7% | 416,0 k € | +4.7% | 397,2 k € | +19.3% | 332,9 k € | -11.6% | 376,5 k € | |
| Operating profit | 569,9 k € | -5.2% | 601,4 k € | +19.2% | 504,6 k € | -5.1% | 531,8 k € | +36.8% | 388,7 k € | -12.1% | 442,2 k € | +30.9% | 337,9 k € | +39.7% | 241,8 k € | -26.6% | 329,3 k € | +10.0% | 299,4 k € | +3.6% | 289,1 k € | -12.1% | 329,1 k € | +25.6% | 262,0 k € | -44.1% | 468,6 k € | +71.8% | 272,8 k € | +0.9% | 270,3 k € | -4.4% | 282,9 k € | +27.0% | 222,7 k € | -5.4% | 235,4 k € | |
| Profit/loss | 430,8 k € | +1.3% | 425,3 k € | +12.9% | 376,5 k € | +2.4% | 367,6 k € | +33.6% | 275,2 k € | -6.3% | 293,6 k € | +25.8% | 233,3 k € | -41.5% | 398,8 k € | +90.9% | 208,9 k € | +33.5% | 156,5 k € | -21.7% | 199,8 k € | -14.1% | 232,6 k € | +112.8% | 109,3 k € | -69.8% | 362,0 k € | +137.7% | 152,3 k € | -2.8% | 156,7 k € | -18.2% | 191,7 k € | +115.2% | 89,1 k € | -26.6% | 121,3 k € | |
| Equity | 2,5 M € | +20.5% | 2,1 M € | +5.5% | 2,0 M € | +9.8% | 1,8 M € | -6.2% | 1,9 M € | +4.1% | 1,9 M € | +18.8% | 1,6 M € | +17.6% | 1,3 M € | -31.6% | 1,9 M € | +12.1% | 1,7 M € | +9.9% | 1,6 M € | +14.5% | 1,4 M € | +9.6% | 1,3 M € | +9.6% | 1,1 M € | +20.2% | 952,1 k € | +19.0% | 799,8 k € | +24.4% | 643,1 k € | +42.5% | 451,4 k € | +24.6% | 362,4 k € | |
| Total assets | 2,6 M € | +17.6% | 2,2 M € | +5.6% | 2,1 M € | +12.4% | 1,8 M € | -5.7% | 2,0 M € | +2.0% | 1,9 M € | +15.6% | 1,7 M € | -30.8% | 2,4 M € | +12.4% | 2,1 M € | +9.9% | 1,9 M € | +5.7% | 1,8 M € | +10.6% | 1,7 M € | +4.5% | 1,6 M € | +4.1% | 1,5 M € | +13.4% | 1,3 M € | +9.8% | 1,2 M € | +11.1% | 1,1 M € | +16.1% | 950,8 k € | -17.3% | 1,2 M € | |
| Cash | 66,7 k € | -15.3% | 78,7 k € | -93.4% | 1,2 M € | +13.0% | 1,1 M € | -1.0% | 1,1 M € | +20.3% | 890,9 k € | +60.0% | 556,6 k € | -57.6% | 1,3 M € | +51.6% | 866,5 k € | +53.7% | 563,7 k € | +46.8% | 384,1 k € | +32.6% | 289,6 k € | +30.4% | 222,1 k € | +56.0% | 142,4 k € | -70.0% | 474,8 k € | +59.5% | 297,6 k € | +35.5% | 219,7 k € | +1113.0% | 18,1 k € | -90.4% | 189,2 k € | |
| Debts | 5,9 k € | -88.8% | 52,8 k € | -6.1% | 56,3 k € | +58.4% | 35,5 k € | +27.4% | 27,9 k € | -56.4% | 64,0 k € | -35.4% | 99,2 k € | -90.8% | 1,1 M € | +450.2% | 194,9 k € | -8.1% | 212,1 k € | -19.5% | 263,3 k € | -8.3% | 287,3 k € | -14.4% | 335,5 k € | -12.3% | 382,6 k € | -2.8% | 393,8 k € | -7.6% | 426,0 k € | -7.5% | 460,6 k € | -7.8% | 499,4 k € | -36.6% | 787,7 k € | |
Private limited company · Schoten · incorporated on 09/01/2002
Private limited company profitable and well capitalised. Cash position declining (-15.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. BART WOLLAERT is a Private limited company incorporated in 2002. Its main activity is: Specialist medical practice activities. Its registered office is in Schoten.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette